A Concept-to-Commercialization Viral Vector CDMO

Andelyn Biosciences is a gene therapy CDMO with deep expertise and experience in the development and production of viral vectors. With its origins including 20+ years of experience manufacturing viral vectors, Andelyn’s scientific expertise for development and characterization of gene therapies has led to GMP material being produced for over 75+ worldwide clinical trials and 450+ cGMP clinical batches. We support companies developing curative gene therapies for rare and prevalent diseases with plasmid manufacturing, process development, and GMP manufacturing capacity for both adherent and suspension processes up to 2,000L. An advanced digital model, quality system, full regulatory support, and supply chain vertical integration help accelerate the development and manufacturing of our clients' innovative therapies.

Play video

We support clients through all phases of development and commercialization.

Our Name

The name “Andelyn” was chosen to pay tribute to two brave young patients that participated in pivotal clinical trials that make today’s gene therapies possible.

Updates from Andelyn


February 28, 2024

Andelyn Biosciences Selected as Viral Vector Manufacturing Partner for the Foundation for the National Institutes of Health (FNIH) Accelerating Medicines Partnership® (AMP®) Bespoke Gene Therapy Consortium (BGTC)

COLUMBUS, OH, February 28, 2024 – Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and...

News & Media

February 23, 2024

Andelyn Biosciences Announces New Chief Operations Officer

(COLUMBUS, Ohio) – Andelyn Biosciences announces the promotion and appointment of Cyrill Kellerhals as Chief Operations Officer (COO). Cyrill will lead...


January 15, 2024

Andelyn Biosciences and Armatus Bio Partner to Manufacture Suspension-Based AAV Gene Therapy for Rare Neurological Disease Charcot-Marie-Tooth Type 1A (CMT1A)

COLUMBUS, OH, January 15, 2024 – Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and...


December 22, 2023

Three perspectives on the challenges and trends in gene therapy

In this blog, three experts in the field of gene therapy from Andelyn Biosciences give their perspectives on challenges and...

Our Employees Fuel Our Success

Andelyn is made up of an Inspired, Innovative and Compassionate team that contribute towards a rich company culture. We are always looking for great people who want to do great things.